Biosimilars for psoriasis: clinical studies to determine similarity

Biosimilars for psoriasis: clinical studies to determine similarity

Biosimilars are drugs that are similar, but not identical, to originator biologics. Pre-clinical analytical studies are required to show similarity on a molecular and structural level, but efficacy and safety studies in humans are essential to ultimately determine biosimilarity. In this review writt...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	Andrew Blauvelt, L. Puig, Sergio Chimenti, Ronald Vender, Murlidhar Rajagopalan, Ricardo Romiti, Lone Skov, Claus Zachariae, Helen Young, Errol P. Prens, Arnon D. Cohen, J. van der Walt, Jashin J. Wu
Natura:	Revisão
Lingua:	inglese
Pubblicazione:	2016
Accesso online:	https://doi.org/10.1111/bjd.15067
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice
di: Arnon D. Cohen, et al.
Pubblicazione: (2017)

Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis Council
di: Cohen, Arnon D., et al.
Pubblicazione: (2020)

Targeting of interleukin-17 in the treatment of psoriasis
di: Lonnberg, et al.
Pubblicazione: (2014)

Sleep disturbance in psoriasis: a case-controlled study
di: Peter Jensen, et al.
Pubblicazione: (2018)

Targeting of interleukin-17 in the treatment of psoriasis
di: Lønnberg, Ann Sophie, et al.
Pubblicazione: (2014)

New Drugs and Treatment Targets in Psoriasis
di: Klaus F. Kofoed, et al.
Pubblicazione: (2015)

Off-Label Treatments for Pediatric Psoriasis: Lessons for the Clinic
di: Haulrig, Morten B, et al.
Pubblicazione: (2021)

Tildrakizumab: An Evidence-Based Review of Its Use in the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis
di: Näslund-Koch, Charlotte, et al.
Pubblicazione: (2020)

How similar are treatment responses to biosimilars in psoriasis patient? A systematic review of statistical margins in comparative clinical trials
di: Wan, Marilyn T., et al.
Pubblicazione: (2017)

Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council
di: Bruce Strober, et al.
Pubblicazione: (2019)

Cohort profile: the clinical ‘Psoriasis in Adolescents’ (PIA) cohort in Denmark
di: Blegvad, Christoffer, et al.
Pubblicazione: (2019)

Patients with psoriasis have a dysbiotic taxonomic and functional gut microbiota*
di: Tanja Todberg, et al.
Pubblicazione: (2022)

Biologics use in Indian psoriasis patients
di: Rajagopalan, Murlidhar, et al.
Pubblicazione: (2016)

Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis
di: Alexander Egeberg, et al.
Pubblicazione: (2017)

Circulating Brodalumab Levels and Therapy Outcomes in Patients With Psoriasis Treated With Brodalumab: A Case Series
di: Enevold, Christian, et al.
Pubblicazione: (2022)

Health-related Quality of Life in Children and Adolescents with Psoriasis: A Systematic Review and Meta-analysis
di: Hilde Randa, et al.
Pubblicazione: (2016)

Outcomes Following a Mandatory Nonmedical Switch From Adalimumab Originator to Adalimumab Biosimilars in Patients With Psoriasis
di: Nikolai Loft, et al.
Pubblicazione: (2021)

Biosimilar Insulins: How Similar is Similar?
di: Heinemann, Lutz, et al.
Pubblicazione: (2011)

Outcomes Following a Mandatory Nonmedical Switch From Adalimumab Originator to Adalimumab Biosimilars in Patients With Psoriasis
di: Loft, Nikolai, et al.
Pubblicazione: (2021)

Treatment and Burden of Disease in a Cohort of Patients with Prurigo Nodularis: A Survey-based Study
di: TODBERG, Tanja, et al.
Pubblicazione: (2020)

Psoriasis and Obesity
di: Peter Jensen, et al.
Pubblicazione: (2016)

Switching from One Biosimilar to Another Biosimilar of the Same Reference Biologic: A Systematic Review of Studies
di: Hillel P. Cohen, et al.
Pubblicazione: (2022)

Can patient-reported outcome measures be used to predict consultation needs in patients with psoriasis?: A survey study
di: Krontoft, Anna Sophie Belling, et al.
Pubblicazione: (2022)

Patient perceptions of clear/almost clear skin in moderate‐to‐severe plaque psoriasis: results of the Clear About Psoriasis worldwide survey
di: April W. Armstrong, et al.
Pubblicazione: (2018)

The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios
di: Rajagopalan, Murlidhar, et al.
Pubblicazione: (2021)

Phase III randomized study of the proposed adalimumab biosimilar GP2017 in psoriasis: impact of multiple switches
di: Andrew Blauvelt, et al.
Pubblicazione: (2018)

Clinical Goals and Barriers to Effective Psoriasis Care
di: Bruce Strober, et al.
Pubblicazione: (2018)

Blood Cell Biomarkers of Inflammation and Cytokine Levels as Predictors of Response to Biologics in Patients with Psoriasis
di: Clara Sophie Bramsen Andersen, et al.
Pubblicazione: (2023)

Analytical Similarity Assessment in Biosimilar Studies
di: Chow, Shein-Chung, et al.
Pubblicazione: (2016)

The Combination of Etanercept and Methotrexate Increases the Effectiveness of Treatment in Active Psoriasis Despite Inadequate Effect of Methotrexate Therapy
di: Claus Zachariae, et al.
Pubblicazione: (2008)

Clinical Goals and Barriers to Effective Psoriasis Care
di: Strober, Bruce E., et al.
Pubblicazione: (2018)

Interleukin-1 and Interleukin-6 in Psoriasis
di: Errol P. Prens, et al.
Pubblicazione: (1990)

Neutrophil Pathways of Inflammation Characterize the Blood Transcriptomic Signature of Patients with Psoriasis and Cardiovascular Disease
di: Kvist-Hansen, Amanda, et al.
Pubblicazione: (2021)

Biosimilar Drugs for Psoriasis: Principles, Present, and Near Future
di: Carrascosa, Jose-Manuel, et al.
Pubblicazione: (2018)

An Update Review of Biosimilars of Adalimumab in Psoriasis – Bioequivalence and Interchangeability
di: Zhou, Xin, et al.
Pubblicazione: (2021)

Biosimilar Drugs for Psoriasis: Principles, Present, and Near Future
di: J.M. Carrascosa, et al.
Pubblicazione: (2018)

Tapinarof for the treatment of psoriasis
di: Sofia Nogueira, et al.
Pubblicazione: (2022)

Association between Vascular Inflammation and Inflammation in Adipose Tissue, Spleen, and Bone Marrow in Patients with Psoriasis
di: Kaiser, Hannah, et al.
Pubblicazione: (2021)

Biosimilars: How similar or dissimilar are they? (Review Article)
di: Simon D. Roger
Pubblicazione: (2006)

Efficacy of Apremilast in Patients with Prurigo Nodularis: A Proof-of-concept Study
di: TODBERG, Tanja, et al.
Pubblicazione: (2020)